Get the Stockscreener App
3.015
0.50%
0.015
Insight Molecular Diagnostics Inc Stock (IMDX) Forecast
The Insight Molecular Diagnostics Inc (IMDX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.9124, representing a -3.40% decrease from the current price of $3.015. The highest analyst price target is $3.2301, and the lowest is $2.5947.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMDX Price Target
Average 5.5611
(+84.45% Upside)
Is Insight Molecular Diagnostics Inc (IMDX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.96 | Neutral |
| STOCH(9,6) | 33.11 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.2373 | Buy |
| ADX(14) | 42.47 | Sell |
| William %R | -69.14 | Neutral |
| CCI(14) | -8.1838 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.947
Buy
|
3.0046
Sell
|
| MA20 |
3.1645
Sell
|
3.1691
Sell
|
| MA50 |
3.694
Sell
|
3.6249
Sell
|
| MA100 |
4.3686
Sell
|
4.0814
Sell
|
| MA200 |
4.7935
Sell
|
4.4268
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, IMDX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on IMDX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.96 indicates that IMDX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.11 indicates that IMDX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that IMDX is oversold. This suggests that IMDX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.47 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -8.1838 indicates that IMDX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IMDX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Insight Molecular Diagnostics Inc financial reports and earnings history, Insight Molecular Diagnostics Inc (IMDX) stock could reach $7.1843 by 2030, $4.3154 by 2040 and $6.5996 by 2050. See the projected annual prices until 2050 of the Insight Molecular Diagnostics Inc stock below:
- Insight Molecular Diagnostics Inc (IMDX) is expected to reach an average price of $7.0771 in 2035, with a high prediction of $7.7265 and a low estimate of $4.7299. This indicates an $134.73% rise from the last recorded price of $3.015.
- Insight Molecular Diagnostics Inc (IMDX) stock is projected to chart a bullish course in 2040, with an average price target of $3.9363, representing an $30.56% surge from its current level. The forecast ranges from a conservative $3.7345 to a sky-high $4.3154.
- Our analysts predict Insight Molecular Diagnostics Inc (IMDX) to jump 70.71% by 2045, soaring from $4.2869 to an average price of $5.1469, potentially reaching $7.7422. While $4.2869 is the low estimate, the potential upside is significant.
- Insight Molecular Diagnostics Inc (IMDX) stock is expected to climb by 2050, reaching an average of $5.3553, a $77.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.5996 and $5.0953, respectively, highlighting the market's uncertainty.
Insight Molecular Diagnostics Inc Stock (IMDX) Year by Year Forecast
Insight Molecular Diagnostics Inc Stock (IMDX) Price Forecast for 2026
The predicted value for Insight Molecular Diagnostics Inc (IMDX) in 2026 is set at an average of $4.965. Estimates vary from a peak of $7.51 to a trough of $2.42, indicating an +64.68% surge from the present price of $3.015.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.7104 | $2.5947 | $3.2301 | -10.10% |
| December, 2026 | $2.6207 | $2.4705 | $3.0505 | -13.08% |
Insight Molecular Diagnostics Inc Stock (IMDX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Insight Molecular Diagnostics Inc (IMDX) is $5.598, with a high forecast of $8.6517 and a low forecast of $2.5442. This indicates an +85.67% increase from the last price of $3.015.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4611 | $2.5442 | $3.7389 | +14.80% |
| February, 2027 | $6.7714 | $3.3512 | $6.9014 | +124.59% |
| March, 2027 | $6.2819 | $5.6415 | $8.6517 | +108.35% |
| April, 2027 | $6.5123 | $4.8872 | $6.6275 | +116.00% |
| May, 2027 | $6.6627 | $6.1827 | $7.6525 | +120.99% |
| June, 2027 | $5.6331 | $5.1541 | $7.653 | +86.83% |
| July, 2027 | $4.4034 | $4.0503 | $6.3332 | +46.05% |
| August, 2027 | $3.9839 | $2.5636 | $4.6135 | +32.14% |
| September, 2027 | $5.1542 | $3.414 | $5.4942 | +70.95% |
| October, 2027 | $5.3846 | $4.8543 | $7.0044 | +78.59% |
| November, 2027 | $5.885 | $4.6948 | $6.3947 | +95.19% |
| December, 2027 | $4.8254 | $4.4302 | $6.175 | +60.05% |
Insight Molecular Diagnostics Inc Stock (IMDX) Price Forecast for 2028
In 2028, Insight Molecular Diagnostics Inc (IMDX) is projected to reach an average price of $5.7022, with a high projection of $8.7934 and a low estimate of $2.6109. This indicates an +89.13% rise from the last price of $3.015.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0659 | $3.6856 | $5.4655 | +34.85% |
| February, 2028 | $4.0662 | $3.6461 | $4.4673 | +34.87% |
| March, 2028 | $3.1566 | $2.8966 | $4.1363 | +4.70% |
| April, 2028 | $3.1652 | $2.8967 | $3.4217 | +4.98% |
| May, 2028 | $2.8711 | $2.6109 | $3.218 | -4.77% |
| June, 2028 | $3.6918 | $2.6113 | $3.8798 | +22.45% |
| July, 2028 | $5.5777 | $3.292 | $5.6027 | +85.00% |
| August, 2028 | $7.6834 | $5.5229 | $8.7934 | +154.84% |
| September, 2028 | $5.4991 | $5.1941 | $7.8452 | +82.39% |
| October, 2028 | $7.725 | $5.0293 | $7.795 | +156.22% |
| November, 2028 | $7.6058 | $6.3254 | $7.7658 | +152.26% |
| December, 2028 | $5.7365 | $5.0565 | $7.796 | +90.27% |
Insight Molecular Diagnostics Inc Stock (IMDX) Price Forecast for 2029
The 2029 price forecast for Insight Molecular Diagnostics Inc Stock (IMDX) is $4.928 on average, with a high prediction of $7.1488 and a low estimate of $2.7072. This represents an +63.45% increase from the previous price of $3.015.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0474 | $2.7072 | $5.8767 | +34.24% |
| February, 2029 | $4.2981 | $2.9326 | $4.8379 | +42.56% |
| March, 2029 | $6.3788 | $4.1533 | $7.1488 | +111.57% |
| April, 2029 | $5.6897 | $4.8396 | $7.1392 | +88.71% |
| May, 2029 | $5.0305 | $4.5755 | $6.3449 | +66.85% |
| June, 2029 | $4.6112 | $3.8312 | $5.611 | +52.94% |
| July, 2029 | $4.4921 | $4.0019 | $4.8315 | +48.99% |
| August, 2029 | $3.7328 | $3.3626 | $4.5524 | +23.81% |
| September, 2029 | $3.2935 | $3.0432 | $4.0496 | +9.24% |
| October, 2029 | $2.9911 | $2.8752 | $3.5103 | -0.79% |
| November, 2029 | $2.9022 | $2.7514 | $3.3316 | -3.74% |
| December, 2029 | $3.7735 | $2.8258 | $4.0207 | +25.16% |
Insight Molecular Diagnostics Inc Stock (IMDX) Price Forecast for 2030
Insight Molecular Diagnostics Inc Stock (IMDX) is expected to reach an average price of $5.893 in 2030, with a high forecast of $8.9351 and a low forecast of $2.8508. This signifies an +95.46% surge from the last price of $3.015.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.4346 | $3.6438 | $7.1843 | +113.42% |
| February, 2030 | $6.5657 | $6.2249 | $8.9351 | +117.77% |
| March, 2030 | $6.7968 | $5.1715 | $6.912 | +125.43% |
| April, 2030 | $6.9481 | $6.4681 | $7.9376 | +130.45% |
| May, 2030 | $5.9192 | $5.4402 | $7.9389 | +96.32% |
| June, 2030 | $4.6903 | $4.3372 | $6.6195 | +55.56% |
| July, 2030 | $4.2716 | $2.8508 | $4.9006 | +41.68% |
| August, 2030 | $5.4427 | $3.7019 | $5.7827 | +80.52% |
| September, 2030 | $6.0441 | $5.143 | $7.2933 | +100.47% |
| October, 2030 | $6.1751 | $4.9843 | $6.4899 | +104.81% |
| November, 2030 | $5.1162 | $4.7207 | $6.4653 | +69.69% |
| December, 2030 | $4.3576 | $3.9768 | $5.7565 | +44.53% |
8.41%
4.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):